Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/3082180

Download in:

View as

General Info

PMID
3082180